C([Sn](CCCC)(CCCC)[C:6]1[NH:10][N:9]=[C:8]([C:11]([O:13][CH2:14][CH3:15])=[O:12])[CH:7]=1)CCC.Br[C:25]1[N:30]2[N:31]=[CH:32][N:33]=[C:29]2[C:28]([NH:34][C:35]2[CH:40]=[CH:39][C:38]([N:41]3[CH2:46][C@@H:45]4[CH2:47][C@H:42]3[CH2:43][N:44]4[CH:48]([CH3:50])[CH3:49])=[CH:37][CH:36]=2)=[N:27][CH:26]=1>C1COCC1.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1>[CH:48]([N:44]1[CH2:43][C@@H:42]2[CH2:47][C@H:45]1[CH2:46][N:41]2[C:38]1[CH:37]=[CH:36][C:35]([NH:34][C:28]2[C:29]3[N:30]([N:31]=[CH:32][N:33]=3)[C:25]([C:6]3[NH:10][N:9]=[C:8]([C:11]([O:13][CH2:14][CH3:15])=[O:12])[CH:7]=3)=[CH:26][N:27]=2)=[CH:40][CH:39]=1)([CH3:50])[CH3:49]A mixture of ethyl 5-(tributylstannyl)-1H-pyrazole-3-carboxylate (109.0 mg, 0.25 mmol) (Heterocyles, 1992, 813-818), (5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[4-((1S,4S)-5-isopropyl-2,5-diazabicyclo[2.2.1]hept-2-yl)-phenyl]amine (163.0 mg, 0.38 mmol), and Pd(PPh3)2Cl2 (27.0 mg, 0.04 mmol) in THF (3 mL) is refluxed for 18 hours. After return to room temperature, solvent is removed under reduced pressure. Purification of the residue by silica gel column chromatography eluting with a mixture of DCM/7N NH3 in methanol (97/3) affords the title compound (35.0 mg, 28%).
読み込み中…